Mediastinal lymphadenopathy in COVID-19: A review of literature
| Autor: | Pahnwat Tonya Taweesedt, Salim Surani |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Mediastinal lymphadenopathy Coronavirus disease 2019 (COVID-19) Coronavirus disease complications 03 medical and health sciences 0302 clinical medicine Medicine Novel corona virus Chest imaging Lymph node enlargement business.industry COVID-19 Minireviews General Medicine Long term coronavirus disease-sequala medicine.disease 030220 oncology & carcinogenesis Heart failure Etiology 030211 gastroenterology & hepatology Viral disease Radiology Sarcoidosis MEDIASTINAL LYMPH NODE ENLARGEMENT business |
| Zdroj: | World Journal of Clinical Cases |
| ISSN: | 2307-8960 |
| DOI: | 10.12998/wjcc.v9.i12.2703 |
| Popis: | A novel coronavirus disease 2019 (COVID-19) is a progressive viral disease that affected people around the world with widespread morbidity and mortality. Patients with COVID-19 infection typically had pulmonary manifestation but can also present with gastrointestinal, cardiac, or neurological system dysfunction. Chest imaging in patients with COVID-19 commonly show bilateral lung involvement with bilateral ground-glass opacity and consolidation. Mediastinal lymphadenopathy can be found due to infectious or non-infectious etiologies. It is commonly found to be associated with malignant diseases, sarcoidosis, and heart failure. Mediastinal lymph node enlargement is not a typical computer tomography of the chest finding of patients with COVID-19 infection. We summarized the literature which suggested or investigated the mediastinal lymph node enlargement in patients with COVID-19 infection. Further studies are needed to better characterize the importance of mediastinal lymphadenopathy in patients with COVID-19 infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|